CyberKnife for hilar lung tumors: report of clinical response and toxicity (Q34331400)

1 August 2017

title

CyberKnife for hilar lung tumors: report of clinical response and toxicity (English)

1 reference

1 August 2017

3

Eric Oermann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

8 August 2024

author name string

Keith Unger

1

1 reference

1 August 2017

Andrew Ju

2

1 reference

1 August 2017

Simeng Suy

4

1 reference

1 August 2017

Xia Yu

5

1 reference

1 August 2017

Saloomeh Vahdat

6

1 reference

1 August 2017

Deepa Subramaniam

7

1 reference

1 August 2017

Anatoly Dritschilo

10

1 reference

1 August 2017

Eric Anderson

11

1 reference

1 August 2017

K. William Harter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

8 August 2024

Sean P. Collins

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

8 August 2024

Brian T. Collins

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

8 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20969774

8 August 2024

publication date

22 October 2010

1 reference

full work available at URL

1 August 2017

https://jhoonline.biomedcentral.com/counter/pdf/10.1186/1756-8722-3-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20969774/?tool=EBI

8 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

http://www.jhoonline.org/content/3//39/abstract

8 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

http://www.jhoonline.org/content/pdf/1756-8722-3-39.pdf

8 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

http://www.jhoonline.org/content/3//39

8 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20969774/pdf/?tool=EBI

8 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

https://europepmc.org/articles/PMC2987864

8 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

https://europepmc.org/articles/PMC2987864?pdf=render

8 August 2024

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20969774

http://link.springer.com/content/pdf/10.1186/1756-8722-3-39.pdf

8 August 2024

1 reference

Crossref

DOI

10.1186/1756-8722-3-39

https://api.crossref.org/works/10.1186/1756-8722-3-39

http://link.springer.com/article/10.1186/1756-8722-3-39/fulltext.html

8 August 2024

1 reference

10.1186/1756-8722-3-39

https://api.crossref.org/works/10.1186/1756-8722-3-39

Journal of Hematology & Oncology

8 August 2024

published in

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

page(s)

39

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

copyright license

start time

22 October 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Respiration tracking in radiosurgery

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

The role of radiotherapy in treatment of stage I non-small cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Extracranial stereotactic radioablation: physical principles.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2987864

Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients

27 October 2018

1 reference

12 December 2020

Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study

1 reference

12 December 2020

Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial

1 reference

12 December 2020

Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study

1 reference

12 December 2020

Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients

1 reference

12 December 2020

Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer

1 reference

12 December 2020

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy

1 reference

12 December 2020

Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study

1 reference

12 December 2020

Identifiers

DOI

10.1186/1756-8722-3-39

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference